APOA2 anticorps (N-Term)
-
- Antigène Voir toutes APOA2 Anticorps
- APOA2 (Apolipoprotein A-II (APOA2))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp APOA2 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- ApoA-II antibody was raised against the N terminal of APOA2
- Purification
- Affinity purified
- Immunogène
- ApoA-II antibody was raised using the N terminal of APOA2 corresponding to a region with amino acids MKLLAATVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLME
- Top Product
- Discover our top product APOA2 Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
ApoA-II Blocking Peptide, catalog no. 33R-6151, is also available for use as a blocking control in assays to test for specificity of this ApoA-II antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of APOA2 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- APOA2 (Apolipoprotein A-II (APOA2))
- Autre désignation
- ApoA-II (APOA2 Produits)
- Synonymes
- anticorps Apo-AII, anticorps ApoA-II, anticorps apoAII, anticorps Alp-2, anticorps ApoAII, anticorps Apoa-2, anticorps Hdl-1, anticorps APOAII, anticorps apoa2, anticorps apoA-II, anticorps cb1032, anticorps wu:fb57h11, anticorps zgc:193613, anticorps apolipoprotein A2, anticorps apolipoprotein A-II, anticorps APOA2, anticorps Apoa2, anticorps apoa2
- Sujet
- This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.
- Poids moléculaire
- 9 kDa (MW of target protein)
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
-